Glycogen storage disease type I patients with hyperlipidemia have no signs of early vascular dysfunction and premature atherosclerosis

被引:4
作者
Schmitt, Johannes [1 ]
Wurm, Michael [2 ]
Schwab, K. Otfried [1 ]
Spiekerkoetter, Ute [1 ]
Hannibal, Luciana [3 ]
Gruenert, Sarah C. [1 ]
机构
[1] Univ Freiburg, Dept Gen Pediat Adolescent Med & Neonatol, Med Ctr, Fac Med, D-79106 Freiburg, Germany
[2] Univ Childrens Hosp Regensburg, Dept Pediat, St Hedwigs Campus, D-93049 Regensburg, Germany
[3] Univ Freiburg, Dept Gen Pediat Adolescent Med & Neonatol, Lab Clin Biochem & Metab, Fac Med,Med Ctr, D-79106 Freiburg, Germany
关键词
Glycogen storage disease; G6PC; Glucose-6-phosphatase; Atherosclerosis; Vascular dysfunction; Cardiovascular disease; INTIMA-MEDIA THICKNESS; FATTY-ACID-COMPOSITION; OXIDATIVE STRESS; ENDOTHELIAL FUNCTION; RISK-FACTORS; CHILDREN; PLASMA; HYPERGLYCEMIA; ULTRASOUND; PREDICTION;
D O I
10.1016/j.numecd.2021.08.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Glycogen storage disease type I (GSD I) is associated with hyperlipidemia, a known risk factor for premature atherosclerosis. Few studies have addressed endothelial dysfunction in patients with GSD I, and these studies yielded controversial results. Methods and results: We investigated vascular dysfunction in a cohort of 32 patients with GSD I (26 GSD Ia, 6 GSD Ib, mean age 20.7 (4.8-47.5) years) compared to 32 age-, gender-, and BMImatched healthy controls using non-invasive techniques such as quantification of carotid intima media thickness, retinal vessel analysis and 24 h-blood pressure measurements. In addition, early biomarkers of inflammatory and oxidative endothelial stress were assessed in blood. Although GSD I patients had a clearly proatherogenic lipid profile, increased oxidative stress, higher levels of high sensitivity C-reactive protein and increased lipoprotein associated phospholipase A2 activity, functional and structural parameters including carotid intima media thickness and retinal vessel diameters did not indicate premature atherosclerosis in this patient cohort. Blood pressure values and pulse wave velocity were comparable in patients and healthy controls, while central blood pressure and augmentation index were higher in GSD patients. Conclusion: Our data suggest that GSD I is not associated with early vascular dysfunction up to the age of at least 20 years. Further studies are needed to elucidate the possibly protective mechanisms that prevent early atherosclerosis is GSD I. Longer follow-up studies are required to assess the long-term risk of vascular disease with increased oxidative stress being present in GSD I patients. (c) 2021 Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.
引用
收藏
页码:3384 / 3392
页数:9
相关论文
共 50 条
[31]   Impact of glycogen storage disease type I on adult daily life: a survey [J].
Garbade, Sven F. ;
Ederer, Viviane ;
Burgard, Peter ;
Wendel, Udo ;
Spiekerkoetter, Ute ;
Haas, Dorothea ;
Gruenert, Sarah C. .
ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
[32]   The potential of dietary treatment in patients with glycogen storage disease type IV [J].
Derks, Terry G. J. ;
Peeks, Fabian ;
de Boer, Foekje ;
Fokkert-Wilts, Marieke ;
van der Doef, Hubert P. J. ;
van den Heuvel, Marius C. ;
Szymanska, Edyta ;
Rokicki, Dariusz ;
Ryan, Patrick T. ;
Weinstein, David A. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2021, 44 (03) :693-704
[33]   Partial correction of neutrophil dysfunction by oral galactose therapy in glycogen storage disease type Ib [J].
Letkemann, Rudolf ;
Wittkowski, Helmut ;
Antonopoulos, Aristotelis ;
Podskabi, Teodor ;
Haslam, Stuart M. ;
Foell, Dirk ;
Dell, Anne ;
Marquardt, Thorsten .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 44 :216-225
[34]   TYPE-I GLYCOGEN-STORAGE-DISEASE - 9 YEARS OF MANAGEMENT WITH CORNSTARCH [J].
CHEN, YT ;
BAZZARRE, CH ;
LEE, MM ;
SIDBURY, JB ;
COLEMAN, RA .
EUROPEAN JOURNAL OF PEDIATRICS, 1993, 152 :S56-S59
[35]   Early carotid atherosclerosis and family history of vascular disease - Specific effects on arterial sites have implications for genetic studies [J].
Jerrard-Dunne, P ;
Markus, HS ;
Steckel, DA ;
Buehler, A ;
von Kegler, S ;
Sitzer, M .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :302-306
[36]   Stone Forming Risk Factors in Patients With Type Ia Glycogen Storage Disease [J].
Scales, Charles D., Jr. ;
Chandrashekar, Aravind S. ;
Robinson, Marnie R. ;
Cantor, David A. ;
Sullivan, Jennifer ;
Haleblian, George E. ;
Leitao, Victor A. ;
Sur, Roger L. ;
Borawski, Kristy M. ;
Koeberl, Dwight ;
Kishnani, Priya S. ;
Preminger, Glenn M. .
JOURNAL OF UROLOGY, 2010, 183 (03) :1022-1025
[37]   TYPE-I GLYCOGEN-STORAGE-DISEASE - KIDNEY INVOLVEMENT, PATHOGENESIS AND ITS TREATMENT [J].
CHEN, YT .
PEDIATRIC NEPHROLOGY, 1991, 5 (01) :71-76
[38]   Renal Calculi as Initial Presenting Symptom of Glycogen Storage Disease (Type 1 A) in Early Infancy [J].
Mirza, Nida ;
Malhotra, Smita ;
Sibal, Anupam .
JOURNAL OF CHILD SCIENCE, 2020, 10 (01) :E45-E47
[39]   Erectile dysfunction as a marker of silent cardiovascular disease in type-2 diabetic patients in Spain. The DIVA (Diabetes and VAscular disease) study [J].
Ramon Gonzalez-Juanatey, Jose ;
Alegria Ezquerra, Eduardo ;
Gomis Barbera, Ramon ;
Salvador Taboada, Maria Jesus ;
Grigorian Shamagian, Lilian ;
Casasnovas Lenguas, Jose Antonio ;
Lopez Garcia-Aranda, Victor ;
Acosta Delgado, Domingo ;
Salvador Rodriguez, Javier ;
Hernandez Mijares, Antonio ;
Matali Gilarranz, Arantxa .
MEDICINA CLINICA, 2009, 132 (08) :291-297
[40]   Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia [J].
Oshita, Akihiko ;
Itamoto, Toshiyuki ;
Amano, Hironobu ;
Ohdan, Hideki ;
Tashiro, Hirotaka ;
Asahara, Toshimasa .
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2008, 15 (02) :200-203